| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 12/01/2010 | CN1780612B Treatment of incontinence with 5HT2C agonists. |
| 12/01/2010 | CN1646154B Albumin-fused anti-angiogenesis peptides |
| 12/01/2010 | CN101899471A Recombinant retrovirus vector for simultaneously expressing antigen-specific receptor and exogenous gene, B-lymphocyte modified by using same and application thereof |
| 12/01/2010 | CN101899105A Recombinant erythropoietin and preparation method thereof |
| 12/01/2010 | CN101899091A Fatty alkyl pentapeptide conjugate, preparation method thereof and application thereof in medical science |
| 12/01/2010 | CN101899084A (3S)-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid kyrine conjugate, preparation method and application thereof |
| 12/01/2010 | CN101899056A Prasugrel hydrobromide polymorph and preparation method thereof |
| 12/01/2010 | CN101899039A Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist |
| 12/01/2010 | CN101897905A Chinese medicament for treating bronchiectasis hemoptysis |
| 12/01/2010 | CN101897877A Traditional Chinese medicine for curing cerebral thrombosis |
| 12/01/2010 | CN101897875A Swelling-diminishing agent |
| 12/01/2010 | CN101897839A Comprehensive utilization method of banana stalks |
| 12/01/2010 | CN101897792A Edema disease treatment medicament |
| 12/01/2010 | CN101897783A Chinese medicinal pills for treating hematochezia |
| 12/01/2010 | CN101897772A Chinese medicinal pills for treating anemia |
| 12/01/2010 | CN101897755A Traditional Chinese medicine preparation for regulating fat, invigorating blood circulation and regulating vital energy and preparation method thereof |
| 12/01/2010 | CN101897727A Method for preparing traditional Chinese medicine tablets |
| 12/01/2010 | CN101897706A Composition containing folic acid and B vitamins and applications thereof |
| 12/01/2010 | CN101560478B Bacillus subtilis subso natto for producing natto kinase and application thereof |
| 12/01/2010 | CN101555204B Preparation method of caffeic acid medicinal raw material |
| 12/01/2010 | CN101239166B Blood-regulating and face-nourishing capsule and preparation thereof |
| 12/01/2010 | CN101239087B Active component for treating cardio-cerebrovascular disease and oral preparation thereof |
| 12/01/2010 | CN101190941B Polypeptide with thrombus dissolving activity and its preparation method and application |
| 12/01/2010 | CN101077356B Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine |
| 12/01/2010 | CN101069746B Composition containing sugar-reducing medicine and antiplatelet medicine |
| 12/01/2010 | CN101011100B Ice cream powder |
| 11/30/2010 | US7842730 includes rapidly excretable perfluororganic compounds e.g. perfluordecalin, perfluoractilbromide, a perfluoroganic additive embodied in the form of a mixture of perfluorinated tertiary amines contains perfluorotripropylamine and coproducts; and phospholipids in the form of a water-salt dispersion |
| 11/30/2010 | CA2482858C Tricyclic thrombin receptor antagonists |
| 11/30/2010 | CA2456817C Alkyne-aryl-naphthyridin-4 (1h)-one derivatives as type iv phosphodiesterase inhibitor |
| 11/25/2010 | WO2010134614A1 SELF-EMULSIFYING COMPOSITION OF ω3 FATTY ACID |
| 11/25/2010 | WO2010103475A3 Use of serine protease inhibitors in the treatment of neutropenia |
| 11/25/2010 | WO2010077867A3 Treating idiopathic thrombocytopenic purpura with compositions comprising extracts of astragalus membranaceus |
| 11/25/2010 | WO2010057142A3 Surface modification of silk fibroin matrices with poly(ethylene glycol) useful as anti adhesion barriers and anti thrombotic materials |
| 11/25/2010 | US20100298528 Cystine knot molecules |
| 11/25/2010 | US20100298445 Optimized Fluorocarbon Emulsions for Blood Substitutes and Other Therapeutic Uses |
| 11/25/2010 | US20100298402 Stilbene derivatives as pstat3/il-6 inhibitors |
| 11/25/2010 | US20100298395 Unsubstituted and substituted 4-benzyl-1,3-dihydro-imidazole-2-thiones acting as specific or selective alpha2 adrenergic agonists and methods for using the same |
| 11/25/2010 | US20100298325 Pyridine derivatives for the treatment of amyloid-related diseases |
| 11/25/2010 | US20100298324 Prolyl Hydroxylase Inhibitors |
| 11/25/2010 | US20100298315 Novel 6-triazolopyridazinesulfanyl benzothiazole and benzimidazole derivatives, method for production thereof and application as medicaments and pharmnaceutical compositions and novel use as met inhibitors |
| 11/25/2010 | US20100298293 Substituted oxazolidinones and their use |
| 11/25/2010 | US20100298286 Organic Compounds |
| 11/25/2010 | US20100298284 Benzamides and related inhibitors of factor xa |
| 11/25/2010 | US20100298266 Hydroxyethylstarch |
| 11/25/2010 | US20100298264 Biodegradable and water-soluble hemostatic material and a method for preparing the same |
| 11/25/2010 | US20100298239 Peptide with multiple epitopes |
| 11/25/2010 | US20100298238 Nontoxic shiga-like toxin mutant compositions and methods |
| 11/25/2010 | US20100298224 Use of mutated antithrombins for treating or preventing coagulation disorders |
| 11/25/2010 | US20100298223 Fibrinogen for treatment of bleeding in trauma and platelet disorders |
| 11/25/2010 | US20100298216 Casein Derived Peptides And Uses Thereof in Therapy |
| 11/25/2010 | US20100297257 Anticoagulant antagonist and hemophillia procoagulant |
| 11/25/2010 | US20100297256 Methods and compositions for inhibiting integrins using tellurium-containing compounds |
| 11/25/2010 | US20100297255 Malleable implants containing demineralized bone matrix |
| 11/25/2010 | US20100297235 Vascular puncture closure systems, devices, and methods using biocompatible synthetic hydrogel compositions |
| 11/25/2010 | US20100297139 Methods and compositions for the treatment of proteinuric diseases |
| 11/25/2010 | US20100297117 Aqueous formulation of erythropoiesis stimulating protein stabilised by antioxidants for parenteral administration |
| 11/25/2010 | US20100297101 Integrin alpha. II .B.beta.3 Specific Antibodies and Peptides |
| 11/25/2010 | US20100297098 Purification of Factor XIII Polypeptides from Biological Materials |
| 11/25/2010 | US20100297078 Method for producing a hydroxyalkyl starch derivative with two linkers |
| 11/25/2010 | US20100297066 Biodegradable peptide releasing polymers |
| 11/25/2010 | US20100297062 Stable Formulations Of Recombinant Human Albumin-Human Granulocyte Colony Stimulating Factor |
| 11/25/2010 | US20100294677 High Concentration Factor VII Polypeptide Formulations Comprising an Aromatic Preservative and an Antioxidant |
| 11/25/2010 | CA2762939A1 Self-emulsifying composition of .omega.3 fatty acid |
| 11/24/2010 | EP2253703A1 Human coagulation factor VII variants |
| 11/24/2010 | EP2253327A1 Pharmaceutical composition containing a compound having angiotensin II antagonistic activity in combination with another compound |
| 11/24/2010 | EP2252303A2 Von willebrand factor specific binders and methods of use therefor |
| 11/24/2010 | EP2252281A2 Blood substitute solution |
| 11/24/2010 | EP1755652B1 Factor ixa for the treatment of bleeding disorders |
| 11/24/2010 | EP1423082B1 Plasma protein matrices and methods for their preparation |
| 11/24/2010 | EP1381375B1 Oligonucleotide compositions and their use to induce differentiation of cells |
| 11/24/2010 | EP1370260B1 Azoles as malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 11/24/2010 | CN1578660B Lactam-containing compounds and derivatives thereof as factor xa inhibitors |
| 11/24/2010 | CN101896204A Compositions and methods for treating purpura |
| 11/24/2010 | CN101896185A Oxazolidinones for the treatment and/or prophylaxis of heart failure |
| 11/24/2010 | CN101892210A Sipunculus nudus plasmin and preparation method thereof |
| 11/24/2010 | CN101891820A Humanized anti-human von willebrand disease factor monoclonal antibody and application thereof |
| 11/24/2010 | CN101891801A Saturated aliphatic chain alcohol RGD (Arginyl-Glycyl-Aspartic acid) pentapeptide diester compound, synthesis method and application thereof |
| 11/24/2010 | CN101891800A Saturated aliphatic chain alcohol RGD pentapeptide ester compound, synthetic method and application thereof |
| 11/24/2010 | CN101891747A Compound capable of inhibiting phosphodiesterase type 5 and preparation method |
| 11/24/2010 | CN101891728A Scutellarein derivative as well as preparation method and application thereof |
| 11/24/2010 | CN101891680A Modulators of atp-binding cassette transporters |
| 11/24/2010 | CN101890181A Swine fibrin glue powder inhalation and preparation method and application thereof |
| 11/24/2010 | CN101890166A Combination of organic compounds |
| 11/24/2010 | CN101890134A Medicament composition having functions of clearing away heat, promoting diuresis and treating stranguria and preparation method thereof |
| 11/24/2010 | CN101890114A Li nation medicament extract and composition with bacteriostatic, anti-inflammatory and hemostasis effects and preparation method thereof |
| 11/24/2010 | CN101890109A Medicament for treating cardiovascular and cerebrovascular diseases |
| 11/24/2010 | CN101890087A Composition containing coptis root, rhubarb and baikal skullcap root |
| 11/24/2010 | CN101890052A Earthworm crystal powder, preparation process and application thereof |
| 11/24/2010 | CN101890041A Peritoneal dialysis solution and preparation method thereof |
| 11/24/2010 | CN101889986A Flunarizine orally disintegrating tablet and preparation method thereof |
| 11/24/2010 | CN101889953A Device and method for manufacturing drug smoke liquid and drug smoke |
| 11/24/2010 | CN101889946A Smokeless black bean moxibustion instrument |
| 11/24/2010 | CN101889687A Selenium-enriched white red-rooted salvia root tea and preparation method thereof |
| 11/24/2010 | CN101057905B Microwave extraction method for cordate houttuynia total flavones |
| 11/23/2010 | US7838644 oversulfation of epiK-N sulfate to obtain an epiK5-amine-O-oversulfate with very high sulfation degree which by subsequent N-sulfation provides new epiK5-N,O-oversulfate-derivatives; free of activity on the coagulation parameters and useful in the cosmetic or pharmaceutical field |
| 11/23/2010 | US7838637 Single-chain multiple antigen-binding molecule, its preparation and use |
| 11/23/2010 | US7838635 CD16A binding proteins and use for the treatment of immune disorders |
| 11/23/2010 | US7838555 Useful in the treatment and prophylaxis of inflammatory conditions or in the amelioration of symptoms resulting from or facilitated by an inflammatory condition in a mammalian animal including human and primate, non-mammalian animal and |
| 11/23/2010 | US7838541 Methods of using aryl ureas to treat diseases mediated by the VEGF induced signal transduction pathway characterized by abnormal angiogenesis or hyperpermeability processes. |
| 11/23/2010 | US7838506 nonpeptidic inhibitors of cathepsin G; genetic diseases, degenerative diseases, DNA damages, neoplasia and/or skin diseases; DNA or polynucleotide sequences having a chain length of at least 60 nucleotides and being substantially not subjected to undergo efficient base pairing |